亚洲 · 财经报刊 · The Economic Times
Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares
Moderna shares plunged after detailed cancer vaccine trial results triggered profit-taking despite reducing melanoma recurrence risk by 42%. Investors weigh commercial prospects,…
在 The Economic Times 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (economictimes.indiatimes.com)
